UPDATE: Target Reached Aspen R206.03 - Next target higherSymmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up.
We had further indicators of confirmation for upside to come.
Price>20
Price>200
Target 1 R206.03
So what now? Well we can expect somewhat a consolidation, and a potential Cup and Handle to form. Then we have the next target above R221.
It might be messy to buy now, but in good time it should present a great opportunity. I'll let you know.
APN
#APN Aspen Pharmacare looking constructive on the weeklies #jseScanned a couple of stocks on the JSE and it was tough to find many decent setups although Aspen is one that stood out for me on the LONG side.
3 reasons I think this setup is constructive and likely goes higher to at least R200
(1) Weekly price action has been making consecutive higher lows since bottoming out in August 2019. (showing relative strength in comparison to the market which has been moving lower.
(2) We are trading above both the 200 week moving average as well as the yearly Pivot.
(3) Divergency on RSI where RSI shows higher lows even though price made an equal low on the last move down.
I think one can buy this at current levels (approx R146.00), using a stop loss as a weekly close below 132 and a target of approximately R200. From a risk standpoint that's a risk of R14 for a target of potentially R54 which is quite decent.
Let's see how we go over the next couple of weeks
JSE:APN Aspen at Important PointAspen is at an important decision point. It is a level of previous volume at R140 where selling occurred. We have been following the stock signs of strength (see posts below). The relative strength is good and volume is increasing as price increases. However, the volume push is declining. The stock still looks strong but we may see a pause at this level. However, a clean break could result in a quick move higher.
JSE:APN Aspen Markup to StartAfter a selling climax (SC) in March 2019 Aspen has been undergoing accumulation. A spring occurred in August and the markup in Phase D after that. Increases in volume on rising prices indicate buying. Volume and volatility has been muted indicating the stock is being held by strong hands. After a backup (BU) at the breakout level and yearly pivot point some indications of volume could indicate price is ready to start the markup.
JSE:APN | Testing 9000 floorPrice has made its way down from the monthly highs near 11300 and is a trading just above the lows we saw in mid-April.
Given the strong downtrend that this share finds itself in, we have no reason to look for longs as yet - only a close above 11300 would interest this trader in a counter-trend buy.
I'd like to see a close below 8860 - this would open the way up for a retest of the early March dip down to 7000.
Flash Note: Aspen Pharmacare (APN)Last week Lester highlighted APN as as "opportunistic buy" after the fall from R290.
It looks like R263 to 264 is still a level where buyers have lined up to take advantage of the fall. This is also in line with the 50dma.
Once again stay cognizant of the USDZAR.
MariusGrobler301 is having a look at this trade for our clients.